Efficacy News and Research

RSS
Insilico Medicine doses first patient in Phase I Trial of ISM6331 for mesothelioma

Insilico Medicine doses first patient in Phase I Trial of ISM6331 for mesothelioma

Genomic insights and new treatment paradigms related to HER2-low breast cancer

Genomic insights and new treatment paradigms related to HER2-low breast cancer

New air-liquid interface method enhances hair follicle formation in skin organoids

New air-liquid interface method enhances hair follicle formation in skin organoids

Study identifies new molecular target for treating keloids

Study identifies new molecular target for treating keloids

Diagnostic guidelines released for limbic-predominant age-related TDP-43 encephalopathy

Diagnostic guidelines released for limbic-predominant age-related TDP-43 encephalopathy

Single dose of novel drug shows tumor-clearing potential in breast cancer models

Single dose of novel drug shows tumor-clearing potential in breast cancer models

Green tea enriched films show promise for treating oral mucositis

Green tea enriched films show promise for treating oral mucositis

Antidepressant fluoxetine found ineffective for early COVID-19 treatment

Antidepressant fluoxetine found ineffective for early COVID-19 treatment

How gut microbiota impacts childhood obesity

How gut microbiota impacts childhood obesity

SHEA calls for continued U.S. partnership with the World Health Organization

SHEA calls for continued U.S. partnership with the World Health Organization

Pregnant women often left out of drug trials, study finds

Pregnant women often left out of drug trials, study finds

Azvudine beats paxlovid in reducing COVID-19 deaths

Azvudine beats paxlovid in reducing COVID-19 deaths

The science of silk fibroin and chitosan: Techniques for biomaterials analysis

The science of silk fibroin and chitosan: Techniques for biomaterials analysis

Meet Wanda: The AI-generated influencer spreading cancer prevention messages

Meet Wanda: The AI-generated influencer spreading cancer prevention messages

Researchers create an atlas of health associations for GLP-1 receptor agonists

Researchers create an atlas of health associations for GLP-1 receptor agonists

Rethinking mental health research through AI-driven simulations

Rethinking mental health research through AI-driven simulations

Antihistamines offer new hope for erythropoietic protoporphyria-related liver disease

Antihistamines offer new hope for erythropoietic protoporphyria-related liver disease

Qigong shows promise in reducing chronic back pain in veterans

Qigong shows promise in reducing chronic back pain in veterans

New research identifies metabolic targets to combat antibiotic-resistant bacterial infections

New research identifies metabolic targets to combat antibiotic-resistant bacterial infections

New approach shows promise in fighting multiple cancers

New approach shows promise in fighting multiple cancers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.